JNJ-26489112

N/A

Report date: 2025/12/02 15:15:43
NME

Base Information

Drug NameJNJ-26489112
Drug Alias NameJNJ-26489112
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated sodium channels inhibitorsN-Type Calcium channels inhibitors
TargetsVoltage-gated sodium channelsN-Type Calcium channels
Therapy Area/IndicationsDepressionEpilepsy, Reflex
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJanssen Research & Development LlcJohnson & Johnson Pharmaceutical Research & Development LLC
Active IndicationsN/A
Inactive IndicationsDepressionEpilepsy, Reflex

Other Information

ATC CodeN/A
Related LinksWikipedia